Clinical Trial: Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants

U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215078) titled 'Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants' on Oct. 08.

Brief Summary: The purpose of this clinical trial is to learn about the dose proportionality on the PK of the study medicine (called atirmociclib) when administered in the various doses range under the fed condition in healthy participants.

This study is seeking participants who are:

1. male and female aged 18 to 65 years are healthy as determined by medical evaluation including medical history, physical examination, and laboratory tests

2. with BMI of 17.5-30.5 kg/m2; and a total body weight >50 k...